Skip to content
Loop Biz – Lifestyle
Author:
ENA Respiratory
ENA Respiratory Receives USPTO Notice of Allowance for Two Patents Covering TLR2 Agonists and Rhinovirus-Mediated COPD Exacerbations
June 15, 2026
ENA Respiratory Successfully Completes First Part of Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections
May 11, 2026
ENA Respiratory Appoints Melissa Faris to Board
April 23, 2026